CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Episodes 113-128 of 380
- MinuteCE®
Emerging First-Line ICI Combination Regimens in Patients With Unresectable HCC
1.00 program credit
Ghassan K. Abou-Alfa, MD
- MinuteCE®
Use of ICI Combination Regimens in Patients With Intermediate-Stage HCC
1.00 program creditGhassan K. Abou-Alfa, MD
Ghassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
Aiwu Ruth He, MD, PhD
Ghassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
Aiwu Ruth He, MD, PhD
Ghassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
Aiwu Ruth He, MD, PhD
Ghassan K. Abou-Alfa, MD
- MinuteCE®
Pivotal Data Supporting First-Line Atezolizumab/Bevacizumab in Unresectable HCC
1.00 program creditAiwu Ruth He, MD, PhD
Ghassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
- MinuteCE®
Pivotal Data Supporting First-Line Durvalumab/Tremelimumab in Unresectable HCC
1.00 program creditGhassan K. Abou-Alfa, MD
Leslie Citrome, MD, MPH
Christoph U. Correll, MD
Leslie Citrome, MD, MPH
Leslie Citrome, MD, MPH
Leslie Citrome, MD, MPH
